Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures
Macarena S. Aloi, Katherine E. Prater, Raymond E. A. Sánchez, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

The miR-25802/KLF4/NF-κB signaling axis regulates microglia-mediated neuroinflammation in Alzheimer’s disease
Kaiyue Zhao, Jianghong Liu, Ting Sun, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 31-48
Closed Access | Times Cited: 12
Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis
Mirolyuba Ilieva
Cells (2024) Vol. 13, Iss. 12, pp. 1063-1063
Open Access | Times Cited: 9
The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
Samar F. Darwish, Abdullah M. M. Elbadry, Amir S. Elbokhomy, et al.
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 20
MicroRNA-based recent research developments in Alzheimer's disease
Jaime Ramirez-Gomez, Sarthak Dalal, Davin Devara, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Unlocking the Therapeutic Promise of miRNAs in Promoting Amyloid-β Clearance for Alzheimer's Disease.
Vajinder Kaur, Aditya Sunkaria
Behavioural Brain Research (2025), pp. 115505-115505
Closed Access
Mesenchymal Stem Cells from Familial Alzheimer’s Patients Express MicroRNA Differently
Lory Jhenifer Rochín-Hernández, Lory Sthephany Rochín-Hernández, Mayte Lizeth Padilla-Cristerna, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1580-1580
Open Access | Times Cited: 4
Sepsis‐associated encephalopathy: Autophagy and miRNAs regulate microglial activation
Nannan Qin, Yanmei Miao, Leiyu Xie, et al.
Physiological Reports (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 4
Enhancing RNA inhibitory activity using clamp-G-modified nucleobases
Sai Pallavi Pradeep, Vikas Kumar, Shipra Malik, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 8, pp. 102120-102120
Open Access | Times Cited: 2
Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease
M. Di Ianni, Miriam Corraliza-Gómez, Tiago Costa-Coelho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9475-9475
Open Access | Times Cited: 2
miR155, TREM2, INPP5D: Disease stage and cell type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
Sam Gandy, Michelle E. Ehrlich
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
Roger Lane, Taher Darreh‐Shori, Candice Junge, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Identification of robust cellular programs using reproducible LDA that impact sex-specific disease progression in different genotypes of a mouse model of AD
Narges Rezaie, Elisabeth Rebboah, Brian A. Williams, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
Roger Lane, Taher Darreh‐Shori, Candice Junge, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Potential Alzheimer’s disease drug targets identified through microglial biology research
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 1
MicroRNAs in microglia: deciphering their role in neurodegenerative diseases
Shweta Jadhav
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues
Carlos Franciney Moreira Vasconcelos, Vinícius Toledo Ribas, Hilda Petrs‐Silva
Cells (2023) Vol. 12, Iss. 17, pp. 2155-2155
Open Access | Times Cited: 4
Silencing miR-155–5p alleviates hippocampal damage in kainic acid-induced epileptic rats via the Dusp14/MAPK pathway
Qiong Fang, Yuehao Cai, Jiali Chi, et al.
Brain Research Bulletin (2024) Vol. 217, pp. 111057-111057
Open Access
Shared Transcriptomic Signatures Reveal Synaptic Pruning as a Link Between Alzheimer's Disease and Epilepsy
Huihong Li, Zhongcong Xie, Yuxuan Tian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA adverse event reporting system database
Shuangshuang Wu, Yiming Qi, Cheng Jiang, et al.
Expert Opinion on Drug Safety (2024)
Closed Access
A state-of-the-art review on miRNA in prevention and treatment of Alzheimer<bold>’</bold>s disease
Xihan Guo
Journal of Zhejiang University (Medical Sciences) (2023) Vol. 52, Iss. 4, pp. 485-498
Open Access
Page 1

Scroll to top